USP22 and neoplasm: Unfortunately, studies also suggest USP22 may function as a tumor suppressor in cancer due to its function in genome stability and frequent loss (both homozygous or heterozygous loss) and downregulation in many cancer types including ovarian, esophagus, colorectal, pancreatic, lung adenocarcinoma, breast and stomach cancers [14, 15].